These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 9459322
21. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece. Ioannou HV, Mitsis M, Eleftheriou A, Matsagas M, Nousias V, Rigopoulos C, Vartholomatos G, Kappas AM. Int Angiol; 2000 Dec; 19(4):314-8. PubMed ID: 11305729 [Abstract] [Full Text] [Related]
22. [Prevalence of genetic prothrombotic factors (factor V Leiden and II20210 prothrombin mutation) in glomerular nephropathies with or without thrombosis]. Martínez Ara J, Gómez Rioja R, Riñón C, García Muñoz MS, Ruiz Caravaca ML, Miguel JL. Nefrologia; 2000 Dec; 20(2):139-44. PubMed ID: 10853194 [Abstract] [Full Text] [Related]
23. [Cerebral venous thrombosis and factor V Leiden mutation]. Meng Q, Pu C. Zhonghua Yi Xue Za Zhi; 2002 Jan 10; 82(1):47-9. PubMed ID: 11953127 [Abstract] [Full Text] [Related]
28. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation. Pablos JL, Caliz RA, Carreira PE, Atsumi T, Serrano L, Amengual O, Santiago B, Khamashta MA, Hughes GR, Gomez-Reino JJ. J Rheumatol; 1999 Mar 10; 26(3):588-90. PubMed ID: 10090167 [Abstract] [Full Text] [Related]
29. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism. Coen D, Zadro R, Honović L, Banfić L, Stavljenić Rukavina A. Croat Med J; 2001 Aug 10; 42(4):488-92. PubMed ID: 11471205 [Abstract] [Full Text] [Related]
32. Increased venous versus arterial thrombosis in the Factor V Leiden mouse. Cooley BC, Chen CY, Schmeling G. Thromb Res; 2007 Aug 10; 119(6):747-51. PubMed ID: 16793123 [Abstract] [Full Text] [Related]
33. The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients. Hatzaki A, Anagnostopoulou E, Metaxa-Mariatou V, Melissinos C, Philalithis P, Iliadis K, Kontaxis A, Liberatos K, Pangratis N, Nasioulas G. Int Angiol; 2003 Mar 10; 22(1):79-82. PubMed ID: 12771861 [Abstract] [Full Text] [Related]
34. Thrombosis in the young: effect of atherosclerotic risk factors on the risk of myocardial infarction associated with prothrombotic factors. Siscovick DS, Schwartz SM, Rosendaal FR, Psaty BM. Thromb Haemost; 1997 Jul 10; 78(1):7-12. PubMed ID: 9198120 [Abstract] [Full Text] [Related]
36. [Venous and arterial thromboembolism in a patient with factor V R506Q Leiden mutation and heparin-induced immuno-allergic reaction]. Letawe-Gilis L, Lambermont B, David JL. Rev Med Liege; 2001 Jul 10; 56(7):493-6. PubMed ID: 11523300 [Abstract] [Full Text] [Related]
38. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Liebman HA, Kashani N, Sutherland D, McGehee W, Kam AL. Gastroenterology; 1998 Oct 10; 115(4):830-4. PubMed ID: 9753484 [Abstract] [Full Text] [Related]
39. Prevalence of factor V Leiden in a Canadian blood donor population. Lee DH, Henderson PA, Blajchman MA. CMAJ; 1996 Aug 01; 155(3):285-9. PubMed ID: 8705907 [Abstract] [Full Text] [Related]
40. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation. Bontempo FA, Hassett AC, Faruki H, Steed DL, Webster MW, Makaroun MS. J Vasc Surg; 1997 Feb 01; 25(2):271-5; discussion 276. PubMed ID: 9052561 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]